InFocus: Life Sciences & Healthcare e-newsletter - October 2006

In this issue we discuss:

• The status of the current debate on disclosure of the origin of traditional and genetic resources in patent applications
• A recent UK patent case which suggests that “work –up” experiments may no longer be privileged
• A change in the UK court rules which allows third parties more access to documents filed at court
• The network of legislation in Europe regulating “pharming”
• The future of the Advanced Therapies Regulation after the recent European Parliament debate
• Greek authorities give Glaxo’s quota system the nod

About Taylor Wessing's Life Sciences & Healthcare Group

Taylor Wessing's market-leading Life Sciences & Healthcare Group provides a top quality, multi-disciplinary service.  The Group combines Taylor Wessing’s top-rated intellectual property and venture capital lawyers with specialists from our highly acclaimed international corporate, corporate finance, employment and real estate practices.  We advise life sciences and healthcare businesses, those who fund them and those who work for them.

For more information about Taylor Wessing's Life Sciences & Healthcare Group, please click here.

For any legal enquiries, please contact Daniel Pavin or your usual contact at Taylor Wessing.  For any marketing and business development enquiries, please contact Sharon Philbey.